SG11201405646TA - Carbohydrate-glycolipid conjugate vaccines - Google Patents
Carbohydrate-glycolipid conjugate vaccinesInfo
- Publication number
- SG11201405646TA SG11201405646TA SG11201405646TA SG11201405646TA SG11201405646TA SG 11201405646T A SG11201405646T A SG 11201405646TA SG 11201405646T A SG11201405646T A SG 11201405646TA SG 11201405646T A SG11201405646T A SG 11201405646TA SG 11201405646T A SG11201405646T A SG 11201405646TA
- Authority
- SG
- Singapore
- Prior art keywords
- carbohydrate
- conjugate vaccines
- glycolipid conjugate
- glycolipid
- vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2012054848 | 2012-03-19 | ||
| PCT/EP2012/002277 WO2013178236A1 (en) | 2012-05-26 | 2012-05-26 | Carbohydrate-glycolipid conjugate vaccines |
| PCT/EP2013/055719 WO2013139803A1 (en) | 2012-03-19 | 2013-03-19 | Carbohydrate-glycolipid conjugate vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201405646TA true SG11201405646TA (en) | 2014-10-30 |
Family
ID=47901120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201405646TA SG11201405646TA (en) | 2012-03-19 | 2013-03-19 | Carbohydrate-glycolipid conjugate vaccines |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10588962B2 (en) |
| EP (1) | EP2827899B1 (en) |
| JP (2) | JP5933106B2 (en) |
| KR (1) | KR101675657B1 (en) |
| CN (1) | CN104321079A (en) |
| AR (1) | AR090386A1 (en) |
| AU (1) | AU2013237497B2 (en) |
| BR (1) | BR112014023193A2 (en) |
| CA (1) | CA2866978C (en) |
| CY (1) | CY1116706T1 (en) |
| DK (1) | DK2827899T3 (en) |
| ES (1) | ES2551599T3 (en) |
| HK (1) | HK1205682A1 (en) |
| HU (1) | HUE028144T2 (en) |
| IL (1) | IL234604A (en) |
| MX (1) | MX337202B (en) |
| PL (1) | PL2827899T3 (en) |
| PT (1) | PT2827899E (en) |
| RU (1) | RU2649009C2 (en) |
| SG (1) | SG11201405646TA (en) |
| SI (1) | SI2827899T1 (en) |
| TW (1) | TWI633112B (en) |
| WO (1) | WO2013139803A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2851092A1 (en) | 2013-09-18 | 2015-03-25 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3 |
| WO2016152980A1 (en) * | 2015-03-24 | 2016-09-29 | 国立大学法人岐阜大学 | Oligonucleotide derivative, oligonucleotide construct using same, and methods for producing these |
| CN106565800B (en) * | 2015-10-08 | 2019-08-13 | 中国人民解放军第二军医大学 | Trisaccharide p methoxy phenol glycosides compound and preparation method thereof |
| TWI732825B (en) * | 2016-05-20 | 2021-07-11 | 日商王子控股股份有限公司 | Oriented self-assembly composition for pattern formation, monomer for orientation self-assembly composition for pattern formation, and pattern formation method |
| CN106620682A (en) * | 2017-01-19 | 2017-05-10 | 华中师范大学 | Liposomal vaccine preparation and use thereof, as well as method for producing IgG antibody |
| KR20200051005A (en) | 2017-09-07 | 2020-05-12 | 머크 샤프 앤드 돔 코포레이션 | Pneumococcal polysaccharide and its use in immunogenic polysaccharide-carrier protein conjugates |
| CN107955082B (en) * | 2017-12-11 | 2019-05-10 | 江南大学 | The preparation method of outer eight sugar of core of Helicobacter pylori lipopolysaccharide |
| CN111760020B (en) * | 2020-05-18 | 2023-05-26 | 广州中医药大学(广州中医药研究院) | Conjugate, preparation method and application thereof |
| CN111760021B (en) * | 2020-05-18 | 2023-06-16 | 广州中医药大学(广州中医药研究院) | Conjugate containing alpha-galactosylceramide analogue and saccharide antigen, and preparation method and application thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5936076A (en) | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
| FI20010118A (en) | 2001-01-19 | 2002-07-20 | Carbion Oy | New receptors for helicobacter pylori and their use |
| WO2003009812A2 (en) | 2001-07-25 | 2003-02-06 | New York University | Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| US8273357B2 (en) * | 2004-07-16 | 2012-09-25 | Massachusetts Institute Of Technology | Antigen-carbohydrate conjugates |
| US8022043B2 (en) | 2004-08-27 | 2011-09-20 | Albert Einstein College Of Medicine Of Yeshiva University | Ceramide derivatives as modulators of immunity and autoimmunity |
| NZ553320A (en) * | 2004-08-27 | 2011-02-25 | Einstein Coll Med | Ceramide derivatives as modulators of immunity and autoimmunity |
| GB0419846D0 (en) * | 2004-09-07 | 2004-10-13 | Chiron Srl | Vaccine adjuvants for saccharides |
| US7923013B2 (en) | 2004-12-28 | 2011-04-12 | The Rockefeller University | Glycolipids and analogues thereof as antigens for NKT cells |
| WO2007051004A2 (en) * | 2005-10-28 | 2007-05-03 | The Brigham And Women's Hospital, Inc. | Conjugate vaccines for non-proteinaceous antigens |
| EP2483287B1 (en) * | 2007-10-12 | 2016-03-16 | Luigi Panza | Analogues of glycolipids useful as immunoadjuvants |
| EP2058011A1 (en) * | 2007-11-07 | 2009-05-13 | Wittycell | Nkt cell activating gycolipids covalently bound antigens and/or drug |
| WO2010083728A1 (en) | 2009-01-23 | 2010-07-29 | Dapeng Zhou | Nanoparticle formulated glycolipid antigens for immunotherapy |
| US8455565B2 (en) | 2011-05-18 | 2013-06-04 | 3M Innovative Properties Company | Disulfide monomers comprising ethylenically unsaturated groups suitable for dental compositions |
-
2013
- 2013-03-19 DK DK13710422.0T patent/DK2827899T3/en active
- 2013-03-19 SI SI201330079T patent/SI2827899T1/en unknown
- 2013-03-19 PL PL13710422T patent/PL2827899T3/en unknown
- 2013-03-19 WO PCT/EP2013/055719 patent/WO2013139803A1/en active Application Filing
- 2013-03-19 CA CA2866978A patent/CA2866978C/en active Active
- 2013-03-19 KR KR1020147029250A patent/KR101675657B1/en active IP Right Grant
- 2013-03-19 US US14/385,948 patent/US10588962B2/en active Active
- 2013-03-19 ES ES13710422.0T patent/ES2551599T3/en active Active
- 2013-03-19 SG SG11201405646TA patent/SG11201405646TA/en unknown
- 2013-03-19 MX MX2014011242A patent/MX337202B/en active IP Right Grant
- 2013-03-19 TW TW102109653A patent/TWI633112B/en active
- 2013-03-19 EP EP13710422.0A patent/EP2827899B1/en active Active
- 2013-03-19 JP JP2015500890A patent/JP5933106B2/en active Active
- 2013-03-19 BR BR112014023193A patent/BR112014023193A2/en not_active Application Discontinuation
- 2013-03-19 HU HUE13710422A patent/HUE028144T2/en unknown
- 2013-03-19 RU RU2014142043A patent/RU2649009C2/en active
- 2013-03-19 CN CN201380015125.5A patent/CN104321079A/en active Pending
- 2013-03-19 AU AU2013237497A patent/AU2013237497B2/en active Active
- 2013-03-19 PT PT137104220T patent/PT2827899E/en unknown
- 2013-03-20 AR ARP130100898A patent/AR090386A1/en unknown
-
2014
- 2014-09-11 IL IL234604A patent/IL234604A/en active IP Right Grant
-
2015
- 2015-06-30 HK HK15106209.7A patent/HK1205682A1/en unknown
- 2015-09-25 CY CY20151100848T patent/CY1116706T1/en unknown
-
2016
- 2016-04-27 JP JP2016089305A patent/JP6235648B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX337202B (en) | 2016-02-17 |
| HK1205682A1 (en) | 2015-12-24 |
| CN104321079A (en) | 2015-01-28 |
| SI2827899T1 (en) | 2015-11-30 |
| ES2551599T3 (en) | 2015-11-20 |
| CA2866978C (en) | 2019-01-29 |
| RU2014142043A (en) | 2016-05-20 |
| CY1116706T1 (en) | 2017-03-15 |
| HUE028144T2 (en) | 2016-11-28 |
| TW201343662A (en) | 2013-11-01 |
| RU2649009C2 (en) | 2018-03-29 |
| JP2015514067A (en) | 2015-05-18 |
| DK2827899T3 (en) | 2015-10-26 |
| KR101675657B1 (en) | 2016-11-11 |
| EP2827899A1 (en) | 2015-01-28 |
| PL2827899T3 (en) | 2015-12-31 |
| KR20140138996A (en) | 2014-12-04 |
| BR112014023193A2 (en) | 2017-08-01 |
| US20150238597A1 (en) | 2015-08-27 |
| AU2013237497B2 (en) | 2016-05-12 |
| WO2013139803A1 (en) | 2013-09-26 |
| AU2013237497A1 (en) | 2014-10-02 |
| CA2866978A1 (en) | 2013-09-26 |
| JP2016183166A (en) | 2016-10-20 |
| IL234604A (en) | 2016-03-31 |
| AR090386A1 (en) | 2014-11-05 |
| US10588962B2 (en) | 2020-03-17 |
| TWI633112B (en) | 2018-08-21 |
| EP2827899B1 (en) | 2015-08-05 |
| PT2827899E (en) | 2015-11-18 |
| MX2014011242A (en) | 2015-03-09 |
| JP6235648B2 (en) | 2017-11-22 |
| JP5933106B2 (en) | 2016-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20182129T1 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
| HK1207967A1 (en) | Vaccine | |
| HUE039329T2 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
| EP2928902A4 (en) | Conjugate compounds | |
| PL2647387T3 (en) | Vaccine Composition | |
| EP2876161A4 (en) | Vaccine | |
| GB201223386D0 (en) | Vaccine | |
| IL234604A (en) | Carbohydrate-glycolipid conjugate vaccines | |
| IL231043A (en) | Vaccine | |
| GB201119999D0 (en) | Vaccine | |
| ZA201409119B (en) | Polymer-nsaid conjugate | |
| EP2763699A4 (en) | Vaccine | |
| ZA201306245B (en) | Combination vaccines | |
| EP2771453A4 (en) | Diatom-based vaccines | |
| EP2822599A4 (en) | Vaccine formulation | |
| GB201120000D0 (en) | Vaccine | |
| DK2846829T3 (en) | Vaccine combinations | |
| GB201217321D0 (en) | Vaccine | |
| GB201210226D0 (en) | Vaccine | |
| GB201206169D0 (en) | Vaccine | |
| GB201205599D0 (en) | Vaccine | |
| GB201202090D0 (en) | Vaccine | |
| GB201210088D0 (en) | Odontalgic preparation | |
| GB201108986D0 (en) | Vaccines | |
| GB201108984D0 (en) | Vaccines |